Search details
1.
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
Prostate
; 84(5): 441-459, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38168866
2.
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.
Prostate
; 82(14): 1378-1388, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35821619
3.
Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms.
Int J Mol Sci
; 23(7)2022 Apr 05.
Article
in English
| MEDLINE | ID: mdl-35409390
4.
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Prostate
; 81(13): 944-955, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34288015
5.
MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
Cancer Lett
; 525: 46-54, 2022 01 28.
Article
in English
| MEDLINE | ID: mdl-34610416
6.
Blocking GRP/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancer.
Transl Oncol
; 14(11): 101213, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34461557
7.
Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro.
Mol Cancer Ther
; 20(2): 398-409, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33298586
8.
FOXA2 promotes prostate cancer growth in the bone.
Am J Transl Res
; 12(9): 5619-5629, 2020.
Article
in English
| MEDLINE | ID: mdl-33042443
9.
Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors.
Am J Clin Exp Urol
; 6(5): 172-181, 2018.
Article
in English
| MEDLINE | ID: mdl-30510969
10.
The role of forkhead box A2 to restrict androgen-regulated gene expression of lipocalin 5 in the mouse epididymis.
Mol Endocrinol
; 20(10): 2418-31, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-16740652
11.
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
Cancer Res
; 77(6): 1331-1344, 2017 03 15.
Article
in English
| MEDLINE | ID: mdl-28108510
12.
Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.
Oncotarget
; 7(38): 61955-61969, 2016 Sep 20.
Article
in English
| MEDLINE | ID: mdl-27542219
13.
The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
Mol Endocrinol
; 17(8): 1484-507, 2003 Aug.
Article
in English
| MEDLINE | ID: mdl-12750453
14.
NF-κB gene signature predicts prostate cancer progression.
Cancer Res
; 74(10): 2763-72, 2014 May 15.
Article
in English
| MEDLINE | ID: mdl-24686169
15.
Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.
PLoS One
; 8(4): e60983, 2013.
Article
in English
| MEDLINE | ID: mdl-23577181
16.
SPARCL1 suppresses metastasis in prostate cancer.
Mol Oncol
; 7(6): 1019-30, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23916135
Results
1 -
16
de 16
1
Next >
>>